CSPAN Washington Journal Avik Roy August 30, 2022
Manufacture drugs . Guest it is interesting because the biotechnology and history and the pharmaceutical industry should have been much more bothered by that. Because that is going to be much more economically impactful to those Companies Bottom lines than the 20 drugs that are being negotiated by the government. I think the trade associations in that sense did themselves no favors by fighting so hard to make more drugs less affordable on the negotiation side, instead of addressing the tax policy which is going to this incentivize and a lot of those companies from being to disincentivise and t...